ST葫芦娃 (605199)
Hainan Huluwa Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 40010.88
- Circulating A-Shares(W): 40010.88
- Earnings Per Share(RMB): -0.0300
- Net Assets Per Share(RMB): 1.7228
- Operating Revenue(W RMB): 68271.99
- Total Profit(W RMB): -321.97
- **Net Profit Attributable to Parent(W RMB) **: -1121.39
- Net Profit Growth Rate(%): 90.46
- Weighted Return on Equity(%): -1.6100
- Operating Cash Flow Per Share(RMB): 0.1460
- Undistributed Profit Per Share(RMB): -0.1655
- Capital Reserve Per Share(RMB): 0.7262
2. Main Business
The main business covers:
- Research, development, production, and sales of proprietary Chinese medicines and chemical drugs.
3. Company Basic Information
- Company Name: Hainan Huluwa Pharmaceutical Group Co., Ltd.
- Listing Date: 2020-07-10
- Industry: Pharmaceuticals & Healthcare - Traditional Chinese Medicine
- Address: No. 8 Yaogu Fourth Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Haikou City, Hainan Province, China
- Website: https://www.huluwayaoye.com/
- Company Profile: The company was established through the overall change of Huluwa Limited. Approved by the shareholders' meeting of Huluwa Limited and the company's founding meeting, it was converted into a joint stock company based on the audited net assets as of December 31, 2015, and completed industrial and commercial registration on March 8, 2016.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hainan Huluwa Investment Development Co., Ltd. | General Legal Person | 16707.90 | 41.76 |
| 2 | Zhejiang Fuwang Jude Health Development Co., Ltd. | General Legal Person | 5751.90 | 14.38 |
| 3 | Hangzhou Zhongjiarui Management Partnership (Limited Partnership) | General Legal Person | 2752.70 | 6.88 |
| 4 | ||||
| 5 | ||||
| 6 | ||||
| 7 | ||||
| 8 | ||||
| 9 | ||||
| 10 |
5. Concept Sectors
- ST Sector
- Hainan Free Trade Port
- Childcare Concept
- Generic Drugs
- Helicobacter Pylori
- Hepatitis Concept
- Innovative Drugs
- Yesterday Limit Up
- Specialized, Refined, Unique, and New (SRUN)
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information
